INPPL1 and hepatocellular carcinoma: As previous studies demonstrated that dysregulation of glucose metabolism is linked to chemoresistance in cancer cells, we determined whether SHIP2 inhibition in HCC cells may affect the sensitivity of these cells to chemotherapy drugs.